Lenington Rachel's Form 4 filing
LeonaBio, Inc. (LONA) · filed Jan 8, 2024
- Accession no.
- 0001209191-24-001138
- Filed
- Jan 8, 2024
- Trade date
- Jan 4-5, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $7.02K. It was filed 4 days after the trade.
This filing was later replaced by the amendment 0001415889-24-004155 (Feb 16, 2024). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lenington RachelCIK 0001861194 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 4, 2024 | Common Stock | AGrant or awardAcquired | +10,000 | $0.00 | $0 | 15,807 | Direct | |
| Jan 5, 2024 | Common Stock | SSaleDisposed | −2,412 | $2.91 | −$7,018.92 | 13,395 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.